News
A new addition to our NGAL portfolio: Anti-NGAL (mouse) antibody pair
August 18 2008
Rat NGAL ELISA launched
June 27 2008
AACC 2008 Annual Meeting, 27-31 July 2008, Washington DC,
June 09 2008
INTERLEC-23 11-16 July 2008, Scotland
June 04 2008
An important addition to our complement antibody collection: Anti-C5b-9 (human) antibody
May 27 2008
New tools for cancer research: Plasminogen Activation System anti-bodies
May 05 2008
Product launch - Anti-NGAL (monkey) antibody
April 10 2008
The Biomarker World Congress 2008, 19-21 May - Philadelphia, USA
April 10 2008
ISICEM, Brussels, Belgium 18-21 March 2008
March 04 2008
BioPorto at ToxExpo, Seattle, Washington 16-20 March 2008
February 13 2008
A new addition to our NGAL portfolio: Anti-NGAL (mouse) antibody pair
August 18 2008 by Janus Guttesen
BioPorto Diagnostics is pleased to announce the launch of a pair of new monoclonal antibodies: ABS 043-10 and ABS 043-29. The antibodies detect mouse NGAL and form an ELISA sandwich pair.
Mice are the most frequently used animals in research, and for the last couple of years many researchers and pharmaceutical companies have been asking for mouse NGAL antibodies.
NGAL as a biomarker of kidney damage is moving closer to being the first biomarker that can cover all the animal models the pharmaceutical industry use when studying toxicology. We are confident that the addition of a sandwich ELISA antibody pair for mouse NGAL will help strengthen NGAL’s position as the preferred biomarker for kidney toxicology studies.
BioPorto Diagnostics will launch these antibodies as a part of the AntibodyShop portfolio, and we expect to expand this part of the research NGAL portfolio even further, with monoclonal antibodies specific for NGAL in other laboratory animals such as pig and dog.
